Mylab launched the HPV RT-PCR test for Risky Cervical Cancers

To Detect and Discriminate the presence of high-risk HPV strains The HPV RT-PCR test is taken. The test has been approved by the regulator in India (Company said).

On Wednesday Company announced the launch of the ‘PathoDetect HPV Detection Test’, a real-time PCR-based screening solution. The test detects high-risk types of human papillomaviruses in individuals.

For 95 percent of cervical cancer, HVP is responsible, It is the second most common cancer among Indian women.

In India, the annual detection of cervical cancer patients is 1.2 lakh.